Allograft colonization and infections with pseudomonas in cystic fibrosis lung transplant recipients

Chest

Volumn 113, Issue 5, 1998, Pages 1235-1243

  Nunley, David R ^a,c   Grgurich, Wayne ^a   Iacono, Aldo T ^a   Yousem, Samuel ^a   Ohori, N Paul ^a   Keenan, Robert J ^b   Dauber, James H ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Cystic fibrosis; Lung transplantation; Pseudomonas

Indexed keywords

ADULT; ALLOGRAFT; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM ISOLATION; CYSTIC FIBROSIS; FEMALE; GRAFT INFECTION; HUMAN; LUNG LAVAGE; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUTROPHIL; PRIORITY JOURNAL; PSEUDOMONAS; RECIPIENT; RESPIRATORY FAILURE;

EID: 0031954753     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.113.5.1235     Document Type: Article

References (31)

1. Cystic Fibrosis Foundation National CF Patient Registry 1994 Annual Data Report. Bethesda, Md: Cystic Fibrosis Foundation, 1995
2. St. Louis International Transplant Registry: September 1995 Report. St. Louis: Washington University in St. Louis, Department of Thoracic Surgery, 1995
3. Flume PA, Egan TM, Paradowski LJ, et al. Infectious complications of lung transplantation: impact of cystic fibrosis. Am J Respir Crit Care Med 1994; 49:1601-07
4. Yousem SA, Berry GJ, Philip CT, et al. Revision of the 1990 formation for the classification of pulmonary allograft rejection: lung rejection study group. J Heart Lung Transplant 1996; 15:1-15
5. Yousem SA. Lymphocytic bronchitis/bronchiolitis in lung allograft recipients. Am J Surg Pathol 1993; 17:491-96
6. The BAL Cooperative Group Steering Committee. Bronchoalveolar lavage constituents in healthy individuals, idiopathic pulmonary fibrosis, and selected comparison groups. Am Rev Respir Dis 1990; 141(suppl):169-202
7. Kramer MR, Marshall SE, Starnes VA, et al. Infectious complications in heart-lung transplantation. Arch Intern Med 1993; 153:2010-16
8. The Registry of the International Society for Heart and Lung Transplantation. Tenth official report - 1993. J Heart Lung Transplant 1993; 12:541-48
9. Smith JJ, Travis SM, Greenberg EP, et al. Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell 1996; 85:229-36
10. Fick RBJ, Fritts LL, Wood RE, et al. Immunochemical analysis of bronchopulmonary proteins in cystic fibrosis. Am Rev Respir Dis 1982; 125:193
11. Wallwork JC, McFarlane H. The SlgA system and hypersensitivity in patients with cystic fibrosis. Clin Allergy 1976; 6:349-58
12. Doring G, Obernesser HJ, Botzenhart K. Extracellular toxins of Pseudomonas aeruginosa: effect of two proteases on human immunoglobulins IgG, IgA, and secretory IgA. Zentral bl Bakteriol Mikrobiol Hyg [A] 1981; 249:89-98
13. Paradis H, Yousem SA, Griffith B. Airway obstruction and bronchiolitis obliterans after lung transplantation. Clin Chest Med 1993; 14:751-63
14. Chan CC, Abi-Saleh WJ, Arroliga AC, et al. Diagnostic yield and therapeutic impact of flexible bronchoscopy in lung transplant recipients. J Heart Lung Transplant 1996; 15:196-205
15. Chastre J, Fargon JY, Bornet Lecso M, et al. Evaluation of bronchoscopic techniques for the diagnosis of nosocomial pneumonia. Am J Respir Crit Care Med 1995; 152:231-40
16. Rouby JJ, de Lasale EM, Poete P, et al. Nosocomial bronchopneumonia in the critically ill: histologic and bacteriologic aspects. Am Rev Respir Dis 1992; 146:1059-66
17. Marquette C, Wallet F, Copin M, et al. Relationship between microbiologic and histologic features in bacterial pneumonia. Am J Respir Crit Care Med 1996; 154:1784-87
18. Trulock EP. Management of lung transplant rejection. Chest 1993; 103:1566-76
19. Konstan MW, Hilliard KA, Norvell TM, et al. Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation. Am J Respir Crit Care Med 1994; 150:448-54
20. Cantin A. Cystic fibrosis lung inflammation: early, sustained, and severe. Am J Respir Crit Care Med 1995; 151:939-41
21. Tang HB, Kays M, Prince A. Role of Pseudomonas aeruginosa pili in acute pulmonary infection. Infect Immun 1995; 63: 1278-85
22. Konstan MW, Byard PJ, Hoppel CL, et al. Effect of high-dose ibuprofen in patients with cystic fibrosis. N Engl J Med 1995; 332:848-54
23. Suter S, Schaad UB, Rous L, et al. Granulocyte neutral proteases and pseudomonas elastase as possible causes of airway damage in patients with cystic fibrosis. J Infect Dis 1984; 149:523-31
24. Tosi M, Zakem H, Berger M. Elastase impairs neutrophil-Pseudomonas interactions: implications for chronic lung infection in cystic fibrosis [abstract]. Pediatr Res 1988; 23:385A
25. Berger M, Sorensen RU, Tosi MF, et al. Complement receptor expression on neutrophils at an inflamatory site, the Pseudomonas infected lung in cystic fibrosis. J Clin Invest 1989; 84:1302-13
26. Starnes VA, Lewiston N, Theodore J, et al. Cystic fibrosis: target population for lung transplantation in North America in the 1990s. J Thorac Cardiovasc Surg 1992; 103:1008-14
27. Nunley DR, Dauber JH, Iacono AT, et al. Neutrophil elastase in bronchoalveolar lavage from transplant recipients with cystic fibrosis [abstract]. Am J Respir Crit Care Med 1996; 153:A262
28. Saiman L, Prince A. Pseudomonas aeruginosa pili bind to asialoGM1 which is increased on the surface of cystic fibrosis epithelial cells. J Clin Invest 1993; 92:1875-80
29. Lewiston N, King V, Umetsu O, et al. Cystic fibrosis patients who have undergone heart-lung transplantation benefit from maxillary sinus antrostomy and repeated sinus lavage. Transplant Proc 1991; 23:1207-08
30. Ramsey BW, Dorkin HL, Eisenberg JD, et al. Efficacy of acrosolized tobramycin in patients with cystic fibrosis. N Engl J Med 1993; 328:1740-46
31. Valerius NH, Koch C, Hoiby N. Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment. Lancet 1991; 338:725-26